The Kidney Biopsy in Lupus Nephritis: Past, Present, and Future

被引:36
|
作者
Parikh, Samir V. [1 ]
Alvarado, Anthony [1 ]
Malvar, Ana [2 ]
Rovin, Brad H. [1 ]
机构
[1] Ohio State Univ, Wexner Med Ctr, Div Nephrol, Columbus, OH 43210 USA
[2] Hosp Fernandez, Nephrol Unit, Buenos Aires, DF, Argentina
关键词
Lupus nephritis; kidney biopsy; systemic lupus erythematosus; RENAL BIOPSY; MYCOPHENOLATE-MOFETIL; INTERSTITIAL INFLAMMATION; PROTEOMIC ANALYSIS; REPEAT BIOPSY; ERYTHEMATOSUS; OUTCOMES; CYCLOPHOSPHAMIDE; IDENTIFICATION; MARKER;
D O I
10.1016/j.semnephrol.2015.08.008
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Since its incorporation into clinical practice in the 1950s, the percutaneous kidney biopsy has played an important role in advancing our understanding of lupus nephritis (LN). The biopsy findings have been used to classify and subgroup LN in order to obtain an accurate diagnosis and also to inform treatment decisions and predict prognosis. Several classifications schemes have been applied clinically however despite this evolution in histopathologic classification, our ability to predict treatment response and determine prognosis remains limited. In this review we will examine the evolving role of the kidney biopsy in the management of LN, including the potentially larger role the biopsy could play in the future. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:465 / 477
页数:13
相关论文
共 50 条